External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Global Health (Medanta) / Equity Bottom-Up

<ul><li>Record Medanta Q1FY26 Performance: Medanta reported revenue of Rs 1,031 Cr, exceeding estimates by 7%, supported by a 4% YoY increase in ARPOB to Rs 66,584 and a 13% YoY growth in occupied bed days, with occupancy at ~63%. </li><li>EBITDA Margins Growth: EBITDA margins stood at 22.0%, down 265 bps QoQ and 190 bps YoY, impacted by annual salary increments and start-up costs related to the Noida unit. </li><li>Encouraging PAT Growth: Reported PAT stood at Rs 159 Cr, up 44.9% YoY and 20% above estimates. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Record Medanta Q1FY26 Performance: Medanta reported revenue of Rs 1,031 Cr, exceeding estimates by 7%, supported by a 4% YoY increase in ARPOB to Rs 66,584 and a 13% YoY growth in occupied bed days, with occupancy at ~63%. EBITDA Margins Growth: EBITDA margins stood at 22.0%, down 265 bps QoQ and 190 bps YoY, impacted by annual salary increments and start-up costs related to the Noida unit. Encouraging PAT Growth: Reported PAT stood at Rs 159 Cr, up 44.9% YoY and 20% above estimates. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Global Health Ltd - Reports Record Growth; Expansion Momentum